コンテンツへスキップ
Merck
  • Glyburide-induced cholestatic hepatitis and liver failure. Case-report and review of the literature.

Glyburide-induced cholestatic hepatitis and liver failure. Case-report and review of the literature.

The Netherlands journal of medicine (1992-06-01)
J P van Basten, B van Hoek, R Zeijen, R Stockbrügger
要旨

As sulphonylurea derivatives are used ubiquitously, the possibility that they may cause liver disease deserves attention. In contrast to the known pattern of reversible parenchymal liver disease due to sulphonylurea derivatives, we describe a fatal case of glyburide-induced cholestatic hepatitis with liver failure.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
グリベンクラミド, ≥99% (HPLC)
Supelco
グリベンクラミド, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Glyburide, meets USP testing specifications
グリベンクラミド, European Pharmacopoeia (EP) Reference Standard
グリベンクラミド, European Pharmacopoeia (EP) Reference Standard